Abstract 05: Efficacy of Phase 1 Clinical Trial of Autologous Quality and Quantity Cultured Vascular and Tissue Regenerative Cell Therapy for Diabetic Patients with Chronic Non Healing Ulcer

Detalles Bibliográficos
Autores principales: Tanaka, Rica, Kado, Makiko, Fujimura, Satoshi, Arita, Kayo, Hirano, Rie, Mizuno, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
PSRC 2018 Abstract Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959535/
http://dx.doi.org/10.1097/01.GOX.0000533870.37733.de
_version_ 1783324413403332608
author Tanaka, Rica
Kado, Makiko
Fujimura, Satoshi
Arita, Kayo
Hirano, Rie
Mizuno, Hiroshi
author_facet Tanaka, Rica
Kado, Makiko
Fujimura, Satoshi
Arita, Kayo
Hirano, Rie
Mizuno, Hiroshi
author_sort Tanaka, Rica
collection PubMed
description
format Online
Article
Text
id pubmed-5959535
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-59595352018-05-29 Abstract 05: Efficacy of Phase 1 Clinical Trial of Autologous Quality and Quantity Cultured Vascular and Tissue Regenerative Cell Therapy for Diabetic Patients with Chronic Non Healing Ulcer Tanaka, Rica Kado, Makiko Fujimura, Satoshi Arita, Kayo Hirano, Rie Mizuno, Hiroshi Plast Reconstr Surg Glob Open PSRC 2018 Abstract Supplement Wolters Kluwer Health 2018-05-07 /pmc/articles/PMC5959535/ http://dx.doi.org/10.1097/01.GOX.0000533870.37733.de Text en Copyright © 2018 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle PSRC 2018 Abstract Supplement
Tanaka, Rica
Kado, Makiko
Fujimura, Satoshi
Arita, Kayo
Hirano, Rie
Mizuno, Hiroshi
Abstract 05: Efficacy of Phase 1 Clinical Trial of Autologous Quality and Quantity Cultured Vascular and Tissue Regenerative Cell Therapy for Diabetic Patients with Chronic Non Healing Ulcer
title Abstract 05: Efficacy of Phase 1 Clinical Trial of Autologous Quality and Quantity Cultured Vascular and Tissue Regenerative Cell Therapy for Diabetic Patients with Chronic Non Healing Ulcer
title_full Abstract 05: Efficacy of Phase 1 Clinical Trial of Autologous Quality and Quantity Cultured Vascular and Tissue Regenerative Cell Therapy for Diabetic Patients with Chronic Non Healing Ulcer
title_fullStr Abstract 05: Efficacy of Phase 1 Clinical Trial of Autologous Quality and Quantity Cultured Vascular and Tissue Regenerative Cell Therapy for Diabetic Patients with Chronic Non Healing Ulcer
title_full_unstemmed Abstract 05: Efficacy of Phase 1 Clinical Trial of Autologous Quality and Quantity Cultured Vascular and Tissue Regenerative Cell Therapy for Diabetic Patients with Chronic Non Healing Ulcer
title_short Abstract 05: Efficacy of Phase 1 Clinical Trial of Autologous Quality and Quantity Cultured Vascular and Tissue Regenerative Cell Therapy for Diabetic Patients with Chronic Non Healing Ulcer
title_sort abstract 05: efficacy of phase 1 clinical trial of autologous quality and quantity cultured vascular and tissue regenerative cell therapy for diabetic patients with chronic non healing ulcer
topic PSRC 2018 Abstract Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959535/
http://dx.doi.org/10.1097/01.GOX.0000533870.37733.de
work_keys_str_mv AT tanakarica abstract05efficacyofphase1clinicaltrialofautologousqualityandquantityculturedvascularandtissueregenerativecelltherapyfordiabeticpatientswithchronicnonhealingulcer
AT kadomakiko abstract05efficacyofphase1clinicaltrialofautologousqualityandquantityculturedvascularandtissueregenerativecelltherapyfordiabeticpatientswithchronicnonhealingulcer
AT fujimurasatoshi abstract05efficacyofphase1clinicaltrialofautologousqualityandquantityculturedvascularandtissueregenerativecelltherapyfordiabeticpatientswithchronicnonhealingulcer
AT aritakayo abstract05efficacyofphase1clinicaltrialofautologousqualityandquantityculturedvascularandtissueregenerativecelltherapyfordiabeticpatientswithchronicnonhealingulcer
AT hiranorie abstract05efficacyofphase1clinicaltrialofautologousqualityandquantityculturedvascularandtissueregenerativecelltherapyfordiabeticpatientswithchronicnonhealingulcer
AT mizunohiroshi abstract05efficacyofphase1clinicaltrialofautologousqualityandquantityculturedvascularandtissueregenerativecelltherapyfordiabeticpatientswithchronicnonhealingulcer

Ejemplares similares